| ADVANCES IN NATURAL MEDICINES AND NUTRACEUTICALS |
27/10/2017 |
8.30 - 10.30 |
| ANTINEOPLASTIC DRUGS |
25/10/2017 |
14.30 - 16.30 |
| CARDIOVASCULAR PHARMACOLOGY I |
26/10/2017 |
18.00 - 19.00 |
| CARDIOVASCULAR PHARMACOLOGY II |
27/10/2017 |
16.00 - 18.00 |
| DRUG ABUSE |
25/10/2017 |
14.30 - 16.30 |
| IMMUNOPHARMACOLOGY |
28/10/2017 |
9.00 - 10.30 |
| INFLAMMATION PHARMACOLOGY |
26/10/2017 |
8.30 - 10.30 |
| KETAMINE AND PHARMACOLOGY OF PSHYCHIATRIC DISEASES |
28/10/2017 |
9.00 - 11.00 |
| MISCELLANEOUS PHARMACOLOGY |
25/10/2017 |
14.30 - 16.30 |
| NEUROPHARMACOLOGY I |
26/10/2017 |
17.00 - 19.00 |
| NEUROPHARMACOLOGY II |
28/10/2017 |
9.00 - 10.30 |
| PHARMACOECONOMICS, PHARMACOEPIDEMIOLOGY & PHARMACOVIGILANCE I |
25/10/2017 |
14.30 - 16.30 |
| PHARMACOECONOMICS, PHARMACOEPIDEMIOLOGY & PHARMACOVIGILANCE II |
28/10/2017 |
9.00 - 11.00 |
| PHARMACOGENETICS, PHARMACOGENOMICS AND GENE THERAPY |
28/10/2017 |
9.00 - 11.00 |
| PHARMACOGNOSY |
27/10/2017 |
14.30 - 15.30 |
| TO SWITCH OR NOT TO SWITCH: THE ROLE OF EXCITATORY AND INHIBITORY GABA TRANSMISSION IN PATHOLOGICAL AND PHYSIOLOGICAL CONDITIONS |
26/10/2017 |
8.30 - 9.30 |
